Hepatopulmonary syndrome: Role of nitric oxide and clinical aspects

Digestive and Liver Disease

Volumn 36, Issue 5, 2004, Pages 303-308

  Rolla, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Hepatopulmonary syndrome; Nitric oxide

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ENDOTHELIN B RECEPTOR ANTAGONIST; METHYLENE BLUE; NITRIC ACID DERIVATIVE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRIC OXIDE SYNTHASE;

ARTERIAL OXYGEN TENSION; BLOOD GAS ANALYSIS; CHRONIC LIVER DISEASE; CLINICAL FEATURE; DISEASE SEVERITY; HEPATOPULMONARY SYNDROME; HUMAN; HYPOXEMIA; LIVER TRANSPLANTATION; LUNG BLOOD VESSEL; NONHUMAN; OXYGENATION; PATHOGENESIS; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; REVIEW; RODENT; SURVIVAL RATE; VASODILATATION; ANIMAL; BIOSYNTHESIS; BLOOD; METABOLISM; PROGNOSIS;

ANIMALS; ANOXEMIA; HEPATOPULMONARY SYNDROME; HUMANS; LIVER TRANSPLANTATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROGNOSIS;

EID: 4544334672     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2003.12.016     Document Type: Review

References (59)

1. Kennedy TC, Knudson RJ. Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis. Chest 1977;72:305-9.
2. Hutchinson DCS, Sapru RP, Sumerling MD, Donaldson GWK, Richmond J. Cirrhosis, cyanosis and polycythaemia: multiple arteriovenous anastomoses. Am J Med 1968;45:139-45.
3. Davis HH, Schwartz DJ, Lefrak SS, Susman N, Schainker BA. Alveolar-capillary oxygen disequilibrium in hepatic cirrhosis. Chest 1978;73:507-11.
4. Furukawa T, Hara N, Yasumoto K, Inokuchi K. Arterial hypoxemia in patients with hepatic cirrhosis. Am J Med Sci 1984;287:10-3.
5. Rodriguez-Roisin R, Roca J, Agusti AG, Mastai R, Wagner PD, Bosch J. Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis 1987;135:1085-92.
6. Krowka MJ, Tajik AJ, Dickson ER, Wiesner RH, Cortese DA. Intrapulmonary vescular dilatations (IPVD) in liver transplant candidates: screening by two-dimensional contrast enhanced echocardiography. Chest 1990;97:1165-70.
7. Hourani JM, Bellamy PE, Taskin DP, Batra B, Simmons MS. Pulmonary dysfunction in advanced liver cirrhosis: frequent occurence of an abnormal diffusing capacity. Am J Med 1991;90:693-700.
8. Battaglia SE, Pretto JJ, Irving LB, Jones RM, Angus PW. Resolution of gas exchange abnormalities and intrapulmonary shunting following liver transplantation. Hepatology 1997;25:1228-32.
9. Krowka MJ, Cortese DA. Hepatopulmonary syndrome: current concepts in diagnostic and therapeutic considerations. Chest 1994;105:1528-37.
10. Berthelot P, Walker JG, Sherlock S, Reid L. Arterial changes in the lungs in cirrhosis of the liver: lung spider nevi. N Engl J Med 1966;274:291-8.
11. Schraufnagel DE, Kay JM. Structural and pathologic changes in the lung vasculature in chronic liver disease. Clin Chest Med 1996;17:1-15.
12. Robin ED, Horn B, Goris ML, Theodore J, Kessel AV, Mazoub J, et al. Detection, quantitation and pathophysiology of lung "spiders". Trans Assoc Am Physicians 1975;88:202-15.
13. Hedenstierna G, Soderman C, Eriksson L, Wahren J. Ventilation-perfusion inequality in patients with non-alcoholuic liver cirrhosis. Eur Respir J 1991;4:711-7.
14. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991;337:776-8.
15. Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 1988;8:232-6.
16. Hokari A, Zeniya M, Esumi H, Kawabe T, Gershwin ME, Toda G. Detection of serum nitrite and nitrate in primary biliary cirrhosis: possible role of nitric oxide in bile duct injury. J Gastroenterol Hepatl 2002;17:308-15.
17. Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balzano J, et al. Increased levels of serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993;18:1139-43.
18. Bauer TM, Schwacha H, Steinbruckner B, Brinkmann FE, Ditzen A, Aponte JJ, et al. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol 2002;97:2364-70.
19. Panos RJ, Backer SK. Mediators, cytokines, and growth factors in liver-lung interactions. Clin Chest Med 1996;17:151-69.
20. Moncada S. Nitric oxide in the vasculature: physiology and pathophysiology. Ann NY Acad Sci 1997;811:60-7.
21. Cahill PA, Redmond EM, Hodges R, Zhang S, Sitzmann JV. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. J Hepatol 1996;25:370-8.
22. Wiest R, Shah V, Sessa WC, Groszmann RJ. Nitric oxide overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am J Physiol 1999;276:G1043-51.
23. Wiest R, Das S, Cadelina G, Garcia-Tsao G, Milstien S, Groszmann RJ. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J Clin Invest 1999;104:1223-33.
24. Añel RML, Sheagren JN. Novel presentation and approach to management of hepatopulmonary syndrome with the use of antimicrobial agents. Clin Infect Dis 2001;32:131-6.
25. Rasaratnam B, Kaye D, Jennings G, Dudley F, Chin-Dusting J. The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial. Ann Intern Med 2003;139:186-93.
26. Rabiller A, Nunes H, Lebrec D, Tazi KA, Wartski M, Dulmet E, et al. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Respir Crit Care Med 2002;166:514-7.
27. Fallon MB, Abrams GA, Luo B, Hou Z, Dai J, Ku DD. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology 1997;113:606-14.
28. Zhang M, Luo B, Chen S, Abrams GA, Fallon MB. Endotelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulmonary syndrome. AJP Gastrointestinal Liver Physiol 1999;277:G944-52.
29. Luo B, Liu L, Tang L, Zhang J, Stockard CR, Grizzle WE, et al. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome. J Hepatol 2003;38:556-63.
30. Ohara N, Futagawa S, Watanabe S, Fukasawa M, Takamori S. Clinical investigation of endothelin-1 and nitric oxide in patients with portal hypertension focusing on plasma levels and immunological staining of liver tissues. Hepatol Res 2001;21:40-54.
31. Bruno CM, Neri S, Scacca C, Caruso L. Plasma endothelin-1 levels in liver cirrhosis. Int J Clin Lab Res 2000;30:169-72.
32. Matsumoto A, Ogura K, Hirata Y, Kakoki M, Watanabe F, Takenaka K, et al. Increased nitric oxide in the exhaled air of patients with decompensated liver cirrhosis. Ann Intern Med 1995;123:110-3.
33. Cremona G, Higenbottam TW, Mayoral V, Alexander G, Demoncheaux E, Borland C, et al. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J 1995;8:1883-5.
34. Rolla G, Brussino L, Colagrande P, Dutto L, Polizzi S, Scappaticci E, et al. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. Hepatology 1997;26:842-7.
35. Delclaux C, Mahut B, Zerah-Lancner F, Delacourt C, Laoud S, Cherqui D, et al. Increased nitric oxide output from alveolar origin during liver cirrhosis versus bronchial source during asthma. Am J Respir Crit Care Med 2002;165:332-7.
36. Rolla G, Bucca C, Brussino L. Methylene blue in the hepatopulmonary sindrome. N Engl J Med 1994;331:1098.
37. Schenk P, Madl C, Rezaie-Majd S, Lehr S, Müller C. Methylene blue improves the hepatopulmonary syndrome. Ann Intern Med 2000;133:701-6.
38. Rolla G, Brussino L, Colagrande P, Scappaticci E, Morello M, Bergerone S, et al. Exhaled nitric oxide and impaired oxygenation in cirrhotic before and after liver transplantation. Ann Intern Med 1998;129:375-8.
39. Brussino L, Bucca C, Morello M, Scappaticci E, Mauro M, Rolla G. Improvement of dyspnoea and hypoxemia by inhaled L-NAME in hepatopulmonary syndrome. Lancet 2003;362:43-4.
40. Carter EP, Hartsfield CL, Miyazono M, Jakkula M, Morris Jr KG, McMurtry IF. Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol 2002;283:L346-53.
41. Hartsfield CL, Alam J, Cook JL, Choi AM. Regulation of heme oxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide. Am J Physiol Lung Cell Mol Physiol 1997;273:L980-98.
42. Ca channels in vascular smooth muscle cells. Pflügers Arch 1997;434:285-91.
43. Zhang J, Ling Y, Luo B, Tang L, Ryter SW, Stockard CR, et al. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome. Gastroenterology 2003;125:1441-51.
44. Rolla G. Is nitric oxide the ultimate mediator in hepatopulmonary syndrome? J Hepatol 2003;38:668-70.
45. Gupta D, Vijaya DR, Gupta R, Dhiman RK, Bhargava M, Verma J, et al. Prevalence of hepatopulmonary syndrome in cirrhosis and extrahepatic portal venous obstruction. Am J Gastroenterol 2001;96:3395-9.
46. 99mTcMAA lung scanning. Chest 2000;118:615-24.
47. Shijo H, Sasaki H, Nishimaru K, Okumura M. Recurrent intracranial hemorrhagic episodes in hepatopulmonary syndrome. Intern Med 1992;31:86-90.
48. Schenk P, Fuhrman V, Madl C, Funk G, Lehr S, Kandel O, et al. Hepatopulmonary syndrome prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 2002;51:853-9.
49. Abrams GA, Nanda NC, Dubovsky EV, Krowka MJ, Fallon MB. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology 1998;114:305-10.
50. Remy J, Remy-Jardin M. Spiral CT, angiography of pulmonary vessels. In: Remy-Jardin M, Remy J, editors. Spiral CT of the chest. Berlin: Springer-Verlag; 2001. p. 232-36.
51. Naeije R. Hepatopulmonary syndrome and portopulmonary hypertension. Swiss Med Wkly 2003;133:163-9.
52. Schenk P, Schöniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Müller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003;125:1042-52.
53. Paramesh AS, Husain SZ, Shneider B, Guller J, Tokat I, Gondolesi GE, et al. Improvement of hepatopulmonary syndrome after transjugular intrahepatic portosystemic shunting: Case report and review of literature. Pediatr Transplant 2003;7:157-62.
54. Corley DA, Scharschmidt B, Bass N, Somberg K, Gold W, Sonnenberg K. Lack of efficacy of TIPS for hepatopulmonary syndrome. Gastroenterology 1997;113:728-30.
55. Krowka MJ, Porayko MK, Plevak DJ, Pappas SC, Steers JL, Krom RA, et al. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc 1997;72:44-53.
56. Taillé C, Cadranel J, Bellocq A, Thabut G, Soubrane O, Durand F, et al. Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France. Transplantation 2003;79:1482-9.
57. Arguedas MR, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 2003;37:192-7.
58. Collisson EA, Nourmand H, Fraiman MH, Cooper CB, Bellamy PE, Farmer DG, et al. Retrospective analysis of the results of liver transplanatation for adults with severe hepatopulmonary disease. Liver Transpl 2002;8:925-31.
59. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-6.